RA0811

antibody from Oursmab

Targeting: VEGFA VEGF, VEGF-A, VPF

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0811

Provider

Oursmab

Product name

Tarcocimab (Biosimilar Reference Antibody) (VEGFA)

Antibody type

Monoclonal

Description

Tarcocimab is a humanized monoclonal antibody targeting vascular endothelial growth factor A (VEGF-A). It binds to VEGF-A to inhibit its interaction with VEGF receptors (VEGFR-1 and VEGFR-2), suppressing angiogenesis and vascular leakage. It is being developed for the treatment of neovascular age-related macular degeneration (nAMD) and other retinal vascular diseases.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Tarcocimab (Biosimilar Reference Antibody) (VEGFA)-RA0811-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.